1/3 L-WAVE ENT 19/2019 14 August 2019 Subject : Management’s Discussion and Analysis for the six-month period ending 30 June 2019 operating results that varied more than 20% compared to the same
1 Ref: CK-20-0000-AFD(AC)-L-0042 August 14, 2020 Subject: Clarification on Operating Result and Financial Position for the six-month period ended June 30, 2020 Attention: President The Stock Exchange
-123.26 -70.72% Operating results for each business segment are shown below: 1. Manufacturing and Selling of Special Cutting Tools unit: THB million 2019 2018 Change (THB million) Change (%) Revenue from
-74.72% Operating results for each business segment are shown below: 1. Manufacturing and Selling of Special Cutting Tools unit: THB million 2019 2018 Change (THB million) Change (%) Revenue from External
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
equipment and IT technology including others relating technology which was launched for the first time in this event. Operating Results Overview Operating results of the Company for three-month and nine-month
13 November 2019 Subject : Explanation of the operating results for the nine months of the year 2019, change in excess of 20% Attention: Directors and Managers the Stock Exchange of Thailand According
follows: S&P Syndicate PCL and subsidiaries operating performance for 2nd quarter Ending 30 Jun 2020 Revenue from Sales and Services In the second quarter of year 2019, the Company and subsidiaries
Operating Results of the Company in Q3/2019 Q3/18 Q3/19 9M/18 9M/19 Change +/(-) (THB million) YoY YoY Operating Revenue 251 283 13% 871 1,194 37% Gross Profit 162 181 12% 582 773 33% EBITDA 76 78 3% 237 362